• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Newsletter Sign Up
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • China Adjusts Import Tariff of Medical Devices

China Adjusts Import Tariff of Medical Devices

Thursday, 27 May 2021 / Published in Medical Device, News, NMPA Registration in China

China Adjusts Import Tariff of Medical Devices

By the end of 2020, the Customs Tariff Committee of the State Council  announced the adjustment of the tariff rate to commence from January 1, 2021, onwards. 883 commodities in China were announced to be under the Most-favoured-nation (MFN) Rate of Duty whilst the import tariff rate on medical equipment such as artificial heart valve and hearing aid reduced from 4% to 1%. Furthermore, a zero tariff is applied to the second batch of anti-cancer drug raw materials and foods required by special children.

The adjustment plan also specifies that the MFN Rate of Duty will be reduced for 176 IT products from July 1, 2021, onwards. The overall average tax rate of products listed in the Information Technology Agreement will be reduced from 0.9% to 0.4% covering nuclear magnetic resonance imaging equipment, cardiac pacemaker, and medical X-ray equipment. The tentative tax rate of nine imported IT products will also be cancelled.

According to the tariff adjustment plan, the tax comparison of medical devices is as follows:

Tax NumberProduct name (Medical Devices)2021
MFN
Tax Rate (%)
2021
Provisional
Tax Rate (%) 
90181100 ECG recorder00
90181210B-type ultrasonic diagnostic apparatus2.61.8
90181291Color Ultrasound Diagnostic Apparatus1.91.3
90181299Other ultrasound scanning devices1.91.3
90181310Complete set of nuclear magnetic resonance imaging device2.41.6
90181390Other MRI imaging devices2.41.6
90181930Patient monitor0.70
90181941Audiometer0.70
90181949Other audiological diagnostic devices0.70
90181990Other electrical diagnostic devices0.70
90182000Ultraviolet and infrared devices00
90185000Other instruments and appliances for ophthalmology0.70
ex 90189020 Electric blood pressure measuring instruments and appliances0.70
90189030Endoscope0.70
90189040Kidney dialysis equipment (artificial kidney)0.70
90189050Diathermy equipment0.70
90189060Blood transfusion equipment0.70
ex 90189070 Electric anesthesia equipment0.70
ex 90189099 Electrosurgical or electronic medical instruments and appliances and their parts and accessories0.70
90215000Pacemaker, excluding parts and accessories0.70
90219011Intravascular stent 0.70
90219019Other stent 0.70
90219090Other orthopedic appliances not listed in tax list 90.210.70
90221200X-ray tomography instrument21.3
90221300Other dental x-ray application equipment00
90221400Other medical or veterinary X-ray application equipment0.70
90221910Low-dose X-ray safety inspection equipment0.70
90222100Medical α、β、γ ray equipment00
ex 90189099 Medical detachable coil41
90200000Other breathing apparatus and gas masks84
90212900Tooth fixture42
ex 90213900 Artificial heart valve41
90214000Hearing aids, excluding parts and accessories41
ex 90219090Cochlear implant device0.7#0Jan-Jun: 0
ex 90229090Parts of the ray generator51
ex 90229090Digital X-ray photography system flat panel detector53
ex 90318090 _Audio life detector, audio and video life detector3#2Jan-Jun: 2

*Note:”Ex” means that the goods subject to the provisional tax rate should fall within the scope of the tax code, subject to the specific description of the product. Before and after “#” are the applicable tax rates for the first half of the year (January 1 to June 30, 2021) and the second half of the year (July 1 to December 31, 2021).

By Colleen Xu. Contact Cisema if you would like to learn more.

Tagged under: Artificial Heart Valve, Hearing Aid, Import Tariff

What you can read next

China Regulatory Framework for AI
DISINFECTANTS IN CHINA: APPROVAL PROCESS AND REVISED STANDARDS
Working Procedures for Medical Device Quality Spot Inspections in China

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • Submission of safety information for cosmetics ingredients

    Submission of safety information for cosmetics raw materials – Draft guidelines issued

    Submission of safety information for cosmetics ...
  • avoid animal testing in Chinaweb-2023

    How to avoid animal testing in China for cosmetics | Cisema Webinar

    China’s beauty and cosmetic market has be...
  • guidelines for medical devices registration

    Guidelines for medical devices registration in China – New development plans in 2023

    Guidelines for medical devices registration in ...
  • China DMF of API

    China DMF of API, Excipient & Packaging Materials: Market & Regulatory | Cisema Webinar

    “China DMF of API, Excipient & Packag...
  • pre-phase III drug clinical trial meeting guidelines

    Pre-phase III drug clinical trial meeting guidelines released

    Pre-phase III drug clinical trial meeting guide...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP